Evidence map›Paper›PMID 30345391›Full record

ArticleWellcome open research2018

Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications.

Keith A Jolley, James E Bray, Martin C J Maiden

Abstract read
In one paragraph

Article in Wellcome open research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2,314 papers.

0numbers the graph read from it
0cells of the map it votes in
2,314citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2,314 citing papers in PubMed.

  1. Dual resistance to carbapenems and colistin inEmerging microbes & infections · 2026
    Article
  2. Article
  3. ElevatedEmerging microbes & infections · 2026
    Article
  4. Carbapenemase-producingEmerging microbes & infections · 2026
    Article
  5. Global spread of carbapenem-resistantOne health (Amsterdam, Netherlands) · 2026
    Article
  6. Article
  7. Emergence of multidrug resistant Enterobacter spp. in Nigeria: a genomic study.World journal of microbiology & biotechnology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Global genomic landscape of theNew microbes and new infections · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. ISmLife · 2026
    Article
  20. Article

2,254 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Keith A JolleyDepartment of Zoology, University of Oxford, Oxford, OX1 3PS, UK.ORCID https://orcid.org/0000-0002-0751-0287
James E BrayDepartment of Zoology, University of Oxford, Oxford, OX1 3PS, UK.ORCID https://orcid.org/0000-0003-3554-4254
Martin C J MaidenDepartment of Zoology, University of Oxford, Oxford, OX1 3PS, UK.ORCID https://orcid.org/0000-0001-6321-5138

Funding

Wellcome Trust
6 · The paper itself

Abstract

The PubMLST.org website hosts a collection of open-access, curated databases that integrate population sequence data with provenance and phenotype information for over 100 different microbial species and genera.  Although the PubMLST website was conceived as part of the development of the first multi-locus sequence typing (MLST) scheme in 1998 the software it uses, the Bacterial Isolate Genome Sequence database (BIGSdb, published in 2010), enables PubMLST to include all levels of sequence data, from single gene sequences up to and including complete, finished genomes.  Here we describe developments in the BIGSdb software made from publication to June 2018 and show how the platform realises microbial population genomics for a wide range of applications.  The system is based on the gene-by-gene analysis of microbial genomes, with each deposited sequence annotated and curated to identify the genes present and systematically catalogue their variation.  Originally intended as a means of characterising isolates with typing schemes, the synthesis of sequences and records of genetic variation with provenance and phenotype data permits highly scalable (whole genome sequence data for tens of thousands of isolates) means of addressing a wide range of functional questions, including: the prediction of antimicrobial resistance; likely cross-reactivity with vaccine antigens; and the functional activities of different variants that lead to key phenotypes.  There are no limitations to the number of sequences, genetic loci, allelic variants or schemes (combinations of loci) that can be included, enabling each database to represent an expanding catalogue of the genetic variation of the population in question.  In addition to providing web-accessible analyses and links to third-party analysis and visualisation tools, the BIGSdb software includes a RESTful application programming interface (API) that enables access to all the underlying data for third-party applications and data analysis pipelines.

Indexed as

Databaseepidemiologyevolutionpopulation annotationpublic health

Identifiers

PMID30345391
PMCPMC6192448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.